For the past two years, Sheba and Mount Sinai have been co-developing novel diagnostic solutions and treatments through the use of artificial intelligence and machine learning.

Sheba and Mount Sinai: Two of the world’s leading medical institutions

Over the past two years, Sheba Medical Center and Mount Sinai Hospital, two of the world’s leading medical institutions, have been collaborating with the aim of advancing the application of artificial intelligence in healthcare. A joint Med AI conference was held on Reichman University’s Herzliya campus to celebrate the two-year collaboration.

During the two-year partnership, Sheba’s innovation arm, ARC (Accelerate, Redesign, Collaborate), and Mount Sinai ran parallel clinical decision support (CDS) teams, collaborating on the collection of big data that will assist clinicians at both facilities in making informed decisions on the diagnosis, treatment, and prognosis of various conditions. As part of this collaboration, AI researchers from Israel participated in an exchange program and traveled to New York to share their expertise.

Sheba and Mount Sinai’s partnership leverages the organizations’ expertise and early adoption of various artificial intelligence platforms, including machine learning algorithms, to develop novel diagnostics and treatments. In addition to advancing new startups focused on developing AI-based clinical tools, Mount Sinai and Sheba continue collaborating to experiment with new technologies in a clinical setting.

Stressing the importance of the partnership at the Med AI conference, Prof. Yitshak Kreiss, Director-General of Sheba Medical Center, explained that “the overarching goal of this collaboration has been to impact patient health with AI, and to subsequently transform healthcare. Together, we are able to build AI systems at scale based on data representing both Sheba and Mount Sinai’s diverse patient populations. These technologies will, in time, support physicians, foster research efforts, and most importantly – promote patient care and wellbeing.”

Prof. David Reich, President of Mount Sinai Health System, who also spoke at the conference, explained: “This collaboration aims to lead the artificial intelligence-driven transformation of healthcare through innovative research and apply new insights to clinical practice – providing personalized care for each patient. These advances will expand Sheba and Mount Sinai’s impact on human health across both hospitals and around the world.”

Leading the digital transformation of healthcare in Israel and around the world, Sheba’s innovation arm, ARC, is dedicated to developing and implementing the processes that would redesign healthcare globally. To that end, Sheba has been building and maintaining close partnerships and projects with the world’s best hospitals and leading international companies, including Mount Sinai Healthcare System.

More Posts